Studio USA

Studio is a biotechnology venture studio focused on building and launching new therapeutic companies from the ground up. Founded by experienced entrepreneurs from Flatiron Health and Bluebird Bio, the company utilizes a centralized platform of operational and scientific expertise to accelerate the development of novel medicines. Studio identifies high-potential scientific breakthroughs and provides the necessary capital, talent, and infrastructure to transition them into independent, clinical-stage biotech entities. Their portfolio spans multiple therapeutic areas, including oncology and rare diseases, leveraging diverse modalities such as small molecules and cell therapies.